
Optic Pathway Gliomas (Revised Article)
Optic pathway gliomas are benign (low grade) pilocytic tumors. They may involve any location in the optic pathway, starting on…
Read MoreOptic pathway gliomas are benign (low grade) pilocytic tumors. They may involve any location in the optic pathway, starting on…
Read MorePeople who themselves have been diagnosed with NF1, NF2 and Schwannomatosis, or who have a child with one of these…
Read MoreVelopharyngeal insufficiency (VPI) is a resonance disorder that occurs during speech that results from the inability of the vellum (or…
Read MoreKOSELUGO FAQS In April 2020 the U.S. Food and Drug Administration (FDA) approved KOSELUGOTM (selumetinib) for use in children over…
Read MoreWe want you to know that we are working from home to do anything we can to continue to support you…
Read MoreNF Midwest has had a very important article written about Malignant Peripheral Nerve Sheath Tumors (or MPNSTs) in Neurofibromatosis Type…
Read MoreDr. James Tonsgard, MD, of the University of Chicago, graciously contributed this article. The article is an overview of Gastrointestinal…
Read MoreNF Midwest is excited to add a new piece about Brainstem Tumors in NF1 to our be iNFormed series. This is…
Read MoreNF Midwest is excited to add another new piece to our be iNFormed series. This is a series of material…
Read MoreChristopher Moertel, MD, director of the neurofibromatosis program at the University of Minnesota, has written NF Midwest’s newest be iNFormed…
Read More
© 2025 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.